Stryker to Buy Pain-Management Company Vertos Medical
Provided by
Dow Jones
By Colin Kellaher
Stryker has agreed to buy privately held Vertos Medical in a deal that expands the medical-device maker's minimally invasive pain-management portfolio.
Stryker on Thursday said Vertos provides a solution for treating chronic lower back pain caused by lumbar spinal stenosis, a narrowing of the spinal canal in the lower back that can cause pain or numbness in the legs.
The Kalamazoo, Mich., company didn't disclose terms of the Vertos deal.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
August 22, 2024 08:39 ET (12:39 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk
United States